Identifeye Working To Put Automated Diabetic Retinopathy Screening In Primary Care Settings

Medtech Insight spoke with Vicky Demas, CEO of Identifeye, about plans for bringing the company’s AI-powered retinal screening system for early detection of diabetic retinopathy to primary care facilities. More than 50% of the roughly 38 million Americans who have diabetes skip retinal screenings at present, increasing risk of developing the leading cause of blindness in adults.

(Identifeye)

Increasingly, retinal imaging is understood to provide insights into eye and systemic health, with links drawn between retinal morphology and cardiovascular, neurological, metabolic and pulmonary diseases.

Physician-researchers from Harvard Medical School, Mass Eye and Ear, Massachusetts General Hospital, and the Broad Institute of MIT and Harvard...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from R&D

More from Leadership